2.3 Endpoints The primary endpoints were area under the plasma concentrationtime curve (AUC) from time 0 to 24 h at steady state (AUC 0-24,SS ) for ethinylestradiol (AUC 0-24,EE,SS ) and levonorgestrel (AUC 0-24,LN,SS ) (Trial 1) and AUC from time zero to infinity (AUC 0- ) for single doses (AUC 0-,SD ) of furosemide (AUC 0-,furo,SD ) and rosuvastatin (AUC 0-,rosu,SD ) (Trial 2)
Every batch produced in a cGMP facility
Waist Size Matters, but It Is Not the Whole Explanation Heart protection also appeared largely unrelated to how much weight participants lost during the first four and a half months of treatment
Preparation Responsible planning and preparation lay the foundation for an effective procedure and smooth recovery
What the human BPC evidence actually shows The broader human BPC evidence base does not resolve this product comparison